BD ChloraPrep Clear, 2% recall — Carefusion 213, LLC (Class II)

Carefusion 213, LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling BD ChloraPrep Clear, 2% — a Class II recall, initiated 2026-07-09 and posted to the FDA enforcement report on 2026-07-22, under recall number D-0690-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator”. From the product description, the form is solution, the strengths given are 2%, 70% and 1 mL and the package is described as 0.03fl oz (1 mL). 1 National Drug Code number is printed in the record: 54365-400-31. Distribution is recorded as “U.S.A. Nationwide” — Nationwide (US), with the recalling firm on record in TX, United States. It is the only recall number the FDA has filed under event ID 99377. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0690-2026
FDA event ID 99377
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Carefusion 213, LLC
Recall initiated 2026-07-09
Reported by FDA 2026-07-22
Report lag 13 days from initiation to report
Distribution U.S.A. Nationwide — Nationwide (US)
Firm location on record TX, United States
Product description (source) BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31

Reason reported by FDA

Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

20 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

6 identifying values matched by exact pattern in the 39-word product description above; each is a literal substring of it.

Product named BD ChloraPrep Clear
Form Solution
Strength 2% · 70% · 1 mL
Package 0.03fl oz (1 mL)
NDC 54365-400-31

Other indexed recalls from Carefusion 213, LLC

17 indexed records name Carefusion 213, LLC as the recalling firm, across 4 FDA events, reported 2026-05-13 to 2026-07-22. A coverage-limited activity count over the ingested window, not a quality rating.

Recall recordRecall numberFDA tierStrength / formReported
BD ChloraPrep Hi-Lite Orange, 2%D-0643-2026Class II2% · Solution2026-07-08
BD PurPrep, 8.3%D-0644-2026Class II8.3% · Solution2026-07-08
BD ChloraPrep Clear, 2%D-0645-2026Class II2% · Solution2026-07-08
ChloraPrep FREPP, 2%D-0646-2026Class II2% · Solution2026-07-08
BD ChloraPrep Hi-Lite Orange, 2%D-0647-2026Class II2% · Solution2026-07-08
BD ChloraPrep Hi-Lite Orange, 2%D-0648-2026Class II2% · Solution2026-07-08
BD ChloraPrep Scrub Teal, 2%D-0649-2026Class II2% · Solution2026-07-08
BD ChloraPrep Scrub Teal, 2%D-0650-2026Class II2% · Solution2026-07-08
BD ChloraPrep CLear, 2%D-0651-2026Class II2% · Solution2026-07-08
BD ChloraPrep CLear, 2%D-0652-2026Class II2% · Solution2026-07-08
BD ChloraPrep Clear, 2%D-0622-2026Class II2% · Solution2026-07-01
BD ChloraPrep FREPP Clear, 2%D-0623-2026Class II2% · Solution2026-07-01

Other indexed recalls of BD ChloraPrep Clear

6 indexed records carry the BD ChloraPrep Clear product name (chlorhexidine gluconate and isopropyl alcohol). Matching is on the product-name prefix of the FDA's own text, so other strengths and packages are included.

Recall recordRecall numberRecalling firmStrength / formReported
BD ChloraPrep Clear, 2%D-0624-2026Carefusion 213, LLC2% · Solution2026-07-01

Reported in the same month (2026-07)

111 enforcement reports carry a report date in 2026-07; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Nystatin Cream USP, 15 gD-0677-2026Padagis US LLCClass II2026-07-22
CVS Health, 6.5%D-0678-2026Bell Pharmaceuticals, IncClass II2026-07-22
Clinere, 0.50 mLD-0679-2026Bell Pharmaceuticals, IncClass II2026-07-22
QC Quality Choice, 6.5%D-0680-2026Bell Pharmaceuticals, IncClass II2026-07-22
TopCare Health, 6.5%D-0681-2026Bell Pharmaceuticals, IncClass II2026-07-22
AUDIOLOGIST'S CHOICE, 6.5%D-0682-2026Bell Pharmaceuticals, IncClass II2026-07-22
FAMILY Wellness, 6.5%D-0683-2026Bell Pharmaceuticals, IncClass II2026-07-22
GOOD NEIGHBOR PHARMACY, 6.5%D-0684-2026Bell Pharmaceuticals, IncClass II2026-07-22

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 54365-400-31 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Carefusion 213, LLC (17 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0690-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0690-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-07-22
Ingested
2026-08-22
Record hash
82b0e5607b28d889

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.